Nathanblack your spot on mate the only one distorting the facts seems to be akrotiri.
The fortune 500 deal looks to have been done with Qualcomm as per annoucement a few weeks back. A bit of a let down from the leading fortune 500 companies that were previously mentioned ISN was going to do a deal with.
As for this part of the news letter,
"We are currently in discussions with several other strategic partners in the medical device and pharmaceutical market in an effort to fully vet all strategic opportunities presented to ISN"
This clearly fails to mention another Fortune 500 company as they already have signed that deal a few weeks ago. This tells us that obviously the deal with the Fortune 500 company isnt going to be enough to get the product out their so they are looking for other NON fortune 500 companies aswell.
If they were in discussions with other Fortune 500 companies then not only would they have said so but i highly doubt Qualcomm would have let them if they have already done a deal with them!
Bit of a mess by the looks, kinda like the cap raisings and the overseas listings.
Cant see any short/medium term price drivers as the Fortune 500 company has already been annouced and the sp went no where.
The only thing thats going to move this is another cap raising which is on the way soon and that price movement will more then likely be down infortunatly.....
currently 2.5 Billion shares on issue and by the end of the year i expect there to be about 4.5 - 5 Billion on issue...
- Forums
- ASX - By Stock
- ISN
- isonea newsletter
isonea newsletter, page-59
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)